Evidence map›Paper›PMID 34521668›Full record

ArticleBMJ open2021

Protein status of people with phenylketonuria: a scoping review protocol.

Sarah Firman, Radha Ramachandran, Kevin Whelan, Oliver C Witard, Majella O'Keeffe

Abstract read
In one paragraph

Article in BMJ open, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

Sarah FirmanDepartment of Nutritional Sciences, King's College London, London, UK.
Radha RamachandranAdult Inherited Metabolic Diseases, Guy's and St Thomas' NHS Foundation Trust, London, UK.
Kevin WhelanDepartment of Nutritional Sciences, King's College London, London, UK.
Oliver C WitardDepartment of Nutritional Sciences, King's College London, London, UK.
Majella O'KeeffeDepartment of Nutritional Sciences, King's College London, London, UK majella.okeeffe@ucc.ie.

Funding

Department of Health NIHR300395
6 · The paper itself

Abstract

introductionPhenylketonuria (PKU) is a disorder of protein metabolism resulting in an accumulation of phenylalanine in the body. Dietary management consists of altering the sources of ingested protein to limit phenylalanine intake. Current dietary protein guidelines for PKU are based on limited scientific evidence, thus it remains unclear whether current practice leads to optimal protein status in people with PKU. To date, no attempt has been made to systematically evaluate the protein status of people with PKU, using a combination of validated anthropometric, biochemical and functional measurement tools. Furthermore, factors known to influence protein status in the general population warrant consideration when determining protein status in individuals with PKU, alongside factors unique to PKU such as the type of protein substitute consumed. Understanding the impact of these variables on protein status is crucial to developing a personalised approach to protein recommendations for optimising health and functional outcomes in people with PKU. Therefore, the aim of this scoping review is to examine existing evidence regarding the protein status of people with PKU, and to investigate the nutritional and lifestyle variables that influence protein status. METHODS AND ANALYSIS: This review will be guided by Arksey and O'Malley's framework, along with guidance from Levac ETHICS AND DISSEMINATION: This review protocol does not require ethical approval. Findings will be disseminated through peer-reviewed publication, presented at relevant conferences, and shared with a patient research advisory group to inform discussions on future research.

Indexed as

PhenylketonuriasDietary ProteinsHumansNutrition PolicyPeer ReviewPhenylalanineResearch DesignScoping Reviews as TopicDietary ProteinsPhenylalaninegeneticsnutrition & dieteticsprotocols & guidelines

Identifiers

PMID34521668
PMCPMC8442069

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.